IL-2 for Kidney Cancer Offers CureIL-2 for Kidney Cancer Offers Cure
High-dose interleukin-2 is still a viable treatment option for metastatic renal cell carcinoma, because it is the only truly curative option for advanced disease. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Hematology | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology